Vardenafil (Levitra / Staxyn): A Clinical Reference for Healthcare Professionals
Vardenafil hydrochloride represents a well-established therapeutic option in the management of erectile dysfunction (ED), a condition affecting millions of men worldwide. As a selective phosphodiesterase type 5 (PDE5) inhibitor, vardenafil is available under the brand names Levitra (film-coated tablets) and Staxyn (orally disintegrating tablets) . At MedArts Pharmacy, we provide healthcare professionals and patients with accurate, evidence-based information to support informed clinical decisions and responsible medication management.
What Is Vardenafil?
Vardenafil is an oral medication approved by the U.S. Food and Drug Administration in 2003 for the treatment of erectile dysfunction . It belongs to the PDE5 inhibitor class, alongside sildenafil (Viagra) and tadalafil (Cialis). Vardenafil is available in two distinct formulations: Levitra film-coated tablets (5 mg, 10 mg, and 20 mg) and Staxyn orally disintegrating tablets (10 mg). Importantly, these formulations are not interchangeable—Staxyn provides higher systemic exposure than the 10 mg Levitra film-coated tablet and is taken without liquid .
How It Works
Vardenafil works by selectively inhibiting PDE5, the enzyme responsible for degrading cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. During sexual stimulation, nitric oxide is released, which increases cGMP levels and promotes smooth muscle relaxation and increased blood flow to the penis. By blocking PDE5, vardenafil prolongs cGMP activity, thereby enhancing erectile function . Sexual stimulation is required for vardenafil to produce an erection.
Benefits and Clinical Advantages
Clinical studies indicate that vardenafil has a relatively rapid onset of action, with some data suggesting effectiveness beginning approximately 25 minutes after dosing . The duration of effect is generally reported as 4 to 5 hours, comparable to sildenafil . The availability of an orally disintegrating formulation (Staxyn) offers an alternative for patients who prefer not to take medication with water, though it is only available in a single 10 mg strength . Generic vardenafil formulations have increased accessibility and affordability for appropriately prescribed patients .
Safety and Responsible Usage Considerations
Vardenafil carries significant cardiovascular considerations. Concomitant use with nitrates in any form is absolutely contraindicated due to the risk of profound hypotension . Patients taking alpha-blockers should not initiate vardenafil therapy with Staxyn; lower-dose film-coated tablets are recommended for initial therapy in these patients . Potent or moderate CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin, erythromycin) are contraindicated with Staxyn . Common adverse reactions include headache, flushing, nasal congestion, and dyspepsia . Rare but serious risks include priapism (erections lasting more than 4 hours), sudden vision loss (NAION), and sudden hearing decrease .
Longevity and Storage Life
Levitra film-coated tablets have a shelf life of 3 years . Vardenafil does not require special storage conditions; store at controlled room temperature, protected from moisture and excessive heat. Staxyn orally disintegrating tablets should be kept in their original blister packaging and taken immediately upon removal .
Ingredients / Composition
The active ingredient is vardenafil hydrochloride trihydrate. Inactive ingredients vary by formulation: Levitra film-coated tablets contain microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, and film coating components. Staxyn orally disintegrating tablets contain aspartame (a source of phenylalanine) and should be avoided in patients with phenylketonuria .
Usage Areas for Healthcare Reference
Vardenafil is indicated for the treatment of erectile dysfunction in adult males. It is not indicated for use in women or pediatric patients. Off-label uses sometimes discussed in medical literature include pulmonary arterial hypertension (for which other PDE5 inhibitors are approved) and altitude illness, but these are not approved indications for vardenafil. For healthcare professionals seeking reliable pharmaceutical information and compliant product sourcing, MedArts Pharmacy serves as a trusted resource committed to accuracy and professional integrity.
